These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy. Rothman MT Br Med J; 1980 Mar; 280(6218):922-3. PubMed ID: 7388371 [No Abstract] [Full Text] [Related]
15. Cardiac arrhythmias associated with disopyramide. Kinney EL; Field EH; Salmon MP; Zelis R N Engl J Med; 1980 May; 302(20):1146. PubMed ID: 7366640 [No Abstract] [Full Text] [Related]
16. [Cardiogenic shock and major intra-ventricular block during treatment with cibenzoline]. Bourrier P; Chennebault JM; Harry P; Broudin S; Selenou M; Alquier P Therapie; 1987; 42(6):561-2. PubMed ID: 3441901 [No Abstract] [Full Text] [Related]
17. Respiratory difficulty after use of disopyramide. Porterfield JG; Antman EM; Lown B N Engl J Med; 1980 Sep; 303(10):584. PubMed ID: 7402225 [No Abstract] [Full Text] [Related]
18. Cardiac problems caused by disopyramide. FDA Drug Bull; 1981 Mar; 11(1):4-5. PubMed ID: 7215732 [No Abstract] [Full Text] [Related]
19. [Electrocardiographic disturbances induced by the simultaneous administration of indapamide and disopyramide]. Cosma C; Pauly-Laubry C; Py J Nouv Presse Med; 1978 Nov; 7(38):3455. PubMed ID: 740527 [No Abstract] [Full Text] [Related]
20. [Cardiogenic shock and major intraventricular block in treatment with cibenzoline]. Aymard Dufour MF; Spriet Pourra C Therapie; 1988 May; 43(3):243-4. PubMed ID: 3420576 [No Abstract] [Full Text] [Related] [Next] [New Search]